Devils Claw Exporter

The global market for Devil's Claw (*Harpagophytum procumbens*) is experiencing steady growth, projected to reach USD 450 million by 2035 with a CAGR of 5.9% Wiseguyreports. Namibia remains the dominant exporter, supplying over 90% of the world's demand, followed by Botswana and South Africa FaoFao.

Market Trends & Insights

• Key Export Destinations: Germany is the primary market where Devil's Claw is a top-three herbal medicine, followed by France and the USA NeweraliveFao.
• Rising Demand Segments: Capsules and powders are surging in the nutraceutical and pharmaceutical sectors due to their clinically demonstrated benefits for joint health and anti-inflammatory properties WiseguyreportsGivaudan.
• Sustainability & Certification: There is a strong market preference for organic and GACP+ (Good Agricultural and Collection Practices) certified products, which command prices significantly higher than conventional material (e.g., US$ 4.2/kg vs. US$ 3.2/kg) WiseguyreportsFao.

Competitive Landscape

The market is characterized by a mix of direct southern African exporters and large Chinese extract manufacturers:

• Southern African Exporters: Leading firms include Harpago (Pty) Ltd and members of the Namibian Devil’s Claw Exporters Association Trust (NDCEAT), which focus on sustainable wild-harvesting and raw material export TravelnamNanci.
• International Processors: A significant portion of the value-added extract is produced by manufacturers in China (e.g., Hunan MT Health Inc., Botanical Cube Inc.), who supply the bulk pharmaceutical and nutraceutical industries globally.

Detailed product listings and supplier profiles are available in the attached files.